Cornerstone Advisory, LLC Zoetis Inc. Transaction History

Cornerstone Advisory, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$165.67 - $199.94 $7,455 - $8,997	-45 Reduced 3.06%	1,424 $240,000
Q4 2023 Feb 13, 2024	BUY	$151.44 - $200.09 $3,028 - $4,001	20 Added 1.38%	1,469 $289,000
Q3 2023 Nov 14, 2023	SELL	$167.14 - $192.77 $22,898 - $26,409	-137 Reduced 8.64%	1,449 $252,000
Q2 2023 Jul 20, 2023	BUY	$160.94 - $186.23 $7,242 - $8,380	45 Added 2.92%	1,586 $273,000
Q1 2023 May 04, 2023	BUY	$145.48 - $175.02 $224,184 - $269,705	1,541 New	1,541 $256,000
Q1 2022 May 20, 2022	SELL	$181.39 - $234.03 $325,050 - $419,381	-1,792 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$193.69 - $247.03 $347,092 - $442,677	1,792 New	1,792 $437,000
Q4 2020 May 11, 2021	SELL	$157.07 - $174.35 $192,567 - $213,753	-1,226 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$137.1 - $165.37 $168,084 - $202,743	1,226 New	1,226 $203,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Cornerstone Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Cornerstone Advisory, LLC with notifications on news.